Advocacy groups urge US to share experimental Ebola drug for outbreak trials

Advocacy groups are pushing the US to release doses of an experimental Ebola drug for trials and emergency use in affected regions, highlighting the urgency as the outbreak escalates. The US government has yet to confirm if these doses will be shared, leaving a critical gap in the international response. This hesitation is raising concerns among health experts and activists who argue that timely access to potential treatments could significantly improve outcomes in affected areas. The situation underscores the global need for transparent and cooperative strategies in addressing emerging health crises.